-
ALSO READ
Astec Life drops after Q3 PAT slumps 97% YoY
Astec Lifesciences consolidated net profit rises 101.87% in the September 2022 quarter
Astec Lifesciences consolidated net profit declines 96.61% in the December 2022 quarter
Astec Lifesciences Ltd leads losers in 'A' group
Relaxo Footwears receives ratings action from ICRA
-
(a) Assigned / Re-affirmed ICRA AA- (Stable) rating for long-term Bank facilities of Rs.556 crore.
Outlook on the long-term rating is revised from Positive to Stable.
(b) Assigned / Re-affirmed ICRA A1+ rating for short-term Bank facilities of Rs.425 crore;
(c) Re-affirmed "ICRA A1+" rating to the existing Rs.300 crore Commercial Paper programme of the Company.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.
Download the Business Standard App for latest Business News and Market News .
RECOMMENDED FOR YOU